#PASCongress

Ataxia therapies: What works, what’s new, and what’s next Ataxias remain among the most therapeutically frustrating disorders in neurology — but recent advances suggest a meaningful shift in the treatment landscape.

Ataxias remain among the most therapeutically frustrating disorders in neurology — but recent advances suggest a meaningful shift in the treatment landscape. #PASCongress https://loom.ly/2tJFVmM

Integrated care in movement disorders: Multidisciplinary models for better outcomes Practical tools and approaches to address a ‘new era’ of PwP — and the real-world examples where they are already working.

Practical tools and approaches to address a ‘new era’ of PwP — and the real-world examples where they are already working. #PASCongress https://loom.ly/gAq1HUg

AI is just a tool, but it matters how we use it Experts delve into how AI works, how our field has already incorporated it into clinical practice and research, and how it may be able to bridge the North-South gap.

Experts delve into how AI works, how our field has already incorporated it into clinical practice and research, and how it may be able to bridge the North-South gap. #PASCongress loom.ly/qRIEzys

How neuroimaging is rapidly transforming the diagnosis and treatment of Parkinson’s disease Experts share how multimodal and alpha-synuclein imaging can offer deeper insights into subtle neurodegeneration across the disease spectrum.

Experts share how multimodal and alpha-synuclein imaging can offer deeper insights into subtle neurodegeneration across the disease spectrum. #PASCongress https://loom.ly/W8tuu3Q

A world-renowned panel of Movement Disorders experts analyzed unique cases live at the #PASCongress Challenging Case Video rounds.

Congratulations to Susan Fox on receiving the 2026 PAS Leadership Award! #PASCongress

More than 230 abstracts are being presented at the #PASCongress. View the published open-access abstracts: https://loom.ly/0F_rvso and Late-Breaking Abstracts: https://loom.ly/S4R4XKU

MDS wishes to acknowledge the following supporters of the 2026 #PASCongress.

MDS wishes to acknowledge the following Bronze Level supporters of the 2026 #PASCongress: Acadia and Amneal Pharmceuticals (Marquee Sponsor).

MDS wishes to acknowledge the following Silver Level supporter of the 2026 #PASCongress: Praxis Precision Medicines.

MDS wishes to acknowledge the following Gold Level supporters of the 2026 #PASCongress: AskBio, Medtronic, Neurocrine Biosciences Inc., and Teva Pharmaceuticals.

MDS wishes to acknowledge the following Platinum Level supporters of the 2026 #PASCongress: Abbvie, Biogen, and Supernus Pharmaceuticals.

Experts debate breakthroughs in disease-modifying therapies for monogenic PD, the relevant role of AI in diagnosis, and whether protein-targeted approaches help or hinder disease progression. #PASCongress pascongress.org

Gain an up-to-date look at current ataxia treatments, emerging disease-modifying strategies, and future innovations including biomarkers and gene therapy. #PASCongress pascongress.org

Browse the cutting-edge #PASCongress scientific sessions and events, including Novel Clinical Trials, Ataxia Therapies, Controversies in Movement Disorders, and more. https://loom.ly/lLFU9S8

It will be a great pleasure to see you again in Houston for the Pan American Parkinson's Disease and Movement Disorders Congress. @movedisorder.bsky.social #PASCongress

Discover how AI tools can analyze data, strengthen movement disorder research, and shape future clinical practice while addressing regional needs. #PASCongress pascongress.org

Preview the hot topics that will be covered during the #PASCongress. https://loom.ly/XIADZ7Q

Hear the latest on trials targeting motor and non-motor symptoms in Parkinson’s, disease-modifying approaches for atypical parkinsonism, and therapies for essential tremor. #PASCongress pascongress.org

Get involved: If you are attending the upcoming #PASCongress, you can become a Social Media Ambassador.

As an official Ambassador, you will encourage others to attend, share about sessions, and capture key moments from the event. Apply now: https://loom.ly/zArMcmE

Last chance: Register for the #PASCongress now for the best rates. pascongress.org/Register

Join us for the #PASCongress to learn about Science, Symptoms, and Solutions in Movement Disorders Across the Americas. View the program-at-a-glance: https://loom.ly/lLFU9S8

Learn how genetic therapies are advancing care for Parkinson's disease, Huntington's disease, and rare metabolic disorders, from preclinical work to clinical trial updates. #PASCongress pascongress.org

Register for the #PASCongress before January 9, 2026 for the best rates. mdscongress.org

Explore new insights in movement disorder hot topics like the dystonia classification, emerging biomarkers, and advances in neuromodulation in this #PASCongress session. pascongress.org

Delve into advancements, discoveries, and trends across the field with leaders from your region at the #PASCongress in Houston, TX, USA. mdscongress.org

Just released: 2026 #PASCongress program-at-a-glance.
View the scientific sessions: https://loom.ly/lLFU9S8

Submit your Late-Breaking Abstract and highlight your novel research at the #PASCongress: https://loom.ly/zm_lMp8

Showcase your research at the 6th #PASCongress in Houston, Texas, February 13–15, 2026. Submit your abstract. https://loom.ly/L8q9Iy0

Present your work to leaders and colleagues across the region. Submit an abstract for presentation at the 6th #PASCongress. https://loom.ly/L8q9Iy0